The legacy of Viagra and its influence on the healthcare landscape presents a intriguing question for shareholders . Initially a hugely successful drug, generics have significantly eroded its market share , https://tomasjjqq467887.jiliblog.com/98093599/the-blue-pill-and-big-pharma-a-risky-opportunity